Logo image of KDLY

KINDLY MD INC (KDLY) Stock Fundamental Analysis

NASDAQ:KDLY - Nasdaq - US49457M1062 - Common Stock - Currency: USD

24.94  +2.11 (+9.24%)

After market: 23.6 -1.34 (-5.37%)

Fundamental Rating

2

Taking everything into account, KDLY scores 2 out of 10 in our fundamental rating. KDLY was compared to 103 industry peers in the Health Care Providers & Services industry. KDLY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. KDLY has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year KDLY has reported negative net income.
KDLY had a negative operating cash flow in the past year.
KDLY Yearly Net Income VS EBIT VS OCF VS FCFKDLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

KDLY has a Return On Assets of -170.60%. This is amonst the worse of the industry: KDLY underperforms 95.15% of its industry peers.
KDLY has a worse Return On Equity (-286.01%) than 79.61% of its industry peers.
Industry RankSector Rank
ROA -170.6%
ROE -286.01%
ROIC N/A
ROA(3y)-171.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KDLY Yearly ROA, ROE, ROICKDLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

KDLY has a better Gross Margin (96.64%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of KDLY has remained more or less at the same level.
KDLY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 96.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.15%
GM growth 5YN/A
KDLY Yearly Profit, Operating, Gross MarginsKDLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100

More info and screens

6

2. Health

2.1 Basic Checks

KDLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
KDLY has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, KDLY has an improved debt to assets ratio.
KDLY Yearly Shares OutstandingKDLY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M
KDLY Yearly Total Debt VS Total AssetsKDLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

An Altman-Z score of 88.79 indicates that KDLY is not in any danger for bankruptcy at the moment.
KDLY has a Altman-Z score of 88.79. This is amongst the best in the industry. KDLY outperforms 100.00% of its industry peers.
KDLY has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of KDLY (0.00) is better than 83.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 88.79
ROIC/WACCN/A
WACC9.04%
KDLY Yearly LT Debt VS Equity VS FCFKDLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M

2.3 Liquidity

A Current Ratio of 2.30 indicates that KDLY has no problem at all paying its short term obligations.
KDLY's Current ratio of 2.30 is amongst the best of the industry. KDLY outperforms 80.58% of its industry peers.
A Quick Ratio of 2.30 indicates that KDLY has no problem at all paying its short term obligations.
KDLY has a Quick ratio of 2.30. This is amongst the best in the industry. KDLY outperforms 83.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.3
Quick Ratio 2.3
KDLY Yearly Current Assets VS Current LiabilitesKDLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for KDLY have decreased strongly by -156.41% in the last year.
Looking at the last year, KDLY shows a very negative growth in Revenue. The Revenue has decreased by -28.12% in the last year.
The Revenue has been growing slightly by 2.79% on average over the past years.
EPS 1Y (TTM)-156.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-182%
Revenue 1Y (TTM)-28.12%
Revenue growth 3Y2.79%
Revenue growth 5YN/A
Sales Q2Q%-30.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KDLY Yearly Revenue VS EstimatesKDLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

KDLY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KDLY Price Earnings VS Forward Price EarningsKDLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KDLY Per share dataKDLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

KDLY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KINDLY MD INC

NASDAQ:KDLY (5/22/2025, 8:19:19 PM)

After market: 23.6 -1.34 (-5.37%)

24.94

+2.11 (+9.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners14.28%
Inst Owner Change0%
Ins Owners2.41%
Ins Owner Change16.89%
Market Cap168.34M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 68.14
P/FCF N/A
P/OCF N/A
P/B 110.09
P/tB 174.04
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS0.37
BVpS0.23
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -170.6%
ROE -286.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 96.64%
FCFM N/A
ROA(3y)-171.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.15%
GM growth 5YN/A
F-Score5
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 435.44%
Cap/Sales 22.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.3
Quick Ratio 2.3
Altman-Z 88.79
F-Score5
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)300.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.84%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-156.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-182%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-28.12%
Revenue growth 3Y2.79%
Revenue growth 5YN/A
Sales Q2Q%-30.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-151.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-649.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-583.85%
OCF growth 3YN/A
OCF growth 5YN/A